Nanobiotix SA
NASDAQ:NBTX
Nanobiotix SA
NASDAQ:NBTX
Price:
28.11
USD
-10.39%
Market Closed
Market Cap:
$1.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nanobiotix SA
NASDAQ:NBTX
|
FR |
|
R
|
Reliance Inc
F:RS6
|
US |
|
I
|
IT City PCL
SET:IT
|
TH |
|
Berkeley Energia Ltd
ASX:BKY
|
AU |
|
F
|
Fresnillo PLC
F:FNL
|
MX |
|
N
|
Nokia Oyj
F:NOAA
|
FI |
|
Sunlands Technology Group
F:S790
|
CN |
|
Delivery Hero SE
F:DHER
|
DE |
|
K
|
KKR & Co Inc
F:KR51
|
US |
|
M
|
Madison Pacific Properties Inc
TSX:MPC
|
CA |
|
N
|
Nokia Oyj
XMUN:NOA3
|
FI |
Intrinsic Value
Not Available for NBTX
There is not enough data to reliably calculate the intrinsic value for Nanobiotix SA.
Do our valuations actually work? See backtest results .
Alternatives to NBTX
Fundamental Analysis
What Nanobiotix Does
Nanobiotix is a French biotechnology company focused on cancer treatment. Its main product is a nanoparticle-based therapy that is designed to be injected into a tumor and activated by radiotherapy, with the goal of making radiation kill more cancer cells while limiting damage to healthy tissue. The company is still building this into an approved medical business rather than selling a broad range of medicines.
- Headquarters
- France FR
- Employees
- 100
- IPO date
- Oct 29, 2012
Financials
Efficiency
Earnings Waterfall
Nanobiotix SA
Nanobiotix SA
